News
Rieter: First Half of 2022 Ad hoc announcement pursuant to Art. 53 LR
Rieter: First Half of 2022
Ad hoc announcement pursuant to Art. 53 LR
Relief Therapeutics Announces that its Collaboration Partner has Resubmitted the ACER-001 (sodium phenylbutyrate) New Drug Application (NDA) to the FDA for the treatment of urea cycle disorders (UCDs)
Relief Therapeutics Announces that its Collaboration Partner has Resubmitted the ACER-001 (sodium phenylbutyrate) New Drug Application (NDA) to the FDA for the treatment of urea cycle disorders (UCDs)
Relief Therapeutics Appoints Serene Forte, Ph.D., MPH, as Senior Vice President, Head of Genetic Medicine
Relief Therapeutics Appoints Serene Forte, Ph.D., MPH, as Senior Vice President, Head of Genetic Medicine
Press release: Leonteq launches a Shari’a compliant offering
Press release: Leonteq launches a Shari’a compliant offering
Partners Group reports robust H1 AuM growth and strong operational performance of portfolio assets
Partners Group reports robust H1 AuM growth and strong operational performance of portfolio assets
Swiss Steel Group records a significant increase in earnings in the second quarter of 2022
Swiss Steel Group records a significant increase in earnings in the second quarter of 2022
Press release: Leonteq launches first products with VP Bank under new innovative issuance model
Press release: Leonteq launches first products with VP Bank under new innovative issuance model
Partners Group acquires off-market last mile logistics portfolio in Finland
Partners Group acquires off-market last mile logistics portfolio in Finland
Extension of the postponement of the settlement of Vifor Pharma tender offer
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220712006199/en/
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
CSL
VAT Media Release on Q2 and HY 2022 Preliminary Results
VAT Media Release on Q2 and HY 2022 Preliminary Results
Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approved Prescription Drug for the Treatment of PKU
Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approved Prescription Drug for the Treatment of PKU
Acquisition completed: ALSO boosts Hungarian coverage
Acquisition completed: ALSO boosts Hungarian coverage
Schindler elevates Singapore’s CapitaSpring skyscraper
Schindler elevates Singapore’s CapitaSpring skyscraper
Comet Holding AG – Presentation of the Half-Year Results 2022
Comet Holding AG – Presentation of the Half-Year Results 2022
INFICON to Publish its Second Quarter and Half-Year 2022 Results on Thursday, July 28, 2022
INFICON to Publish its Second Quarter and Half-Year 2022 Results on Thursday, July 28, 2022
TX Group leads Series A investment into Swiss Fintech Stableton
TX Group leads Series A investment into Swiss Fintech Stableton
Partners Group continues to strengthen transformational investing capabilities with appointment of Wolf-Henning Scheider as Partner and Head of Private Equity
Partners Group continues to strengthen transformational investing capabilities with appointment of Wolf-Henning Scheider as Partner and Head of Private Equity
Partners Group acquires a majority stake in Budderfly, further accelerating the growth of the most comprehensive Energy-as-a-Service provider in North America
Partners Group acquires a majority stake in Budderfly, further accelerating the growth of the most comprehensive Energy-as-a-Service provider in North America
Dufry and Autogrill join forces to redefine Travel Experience globally
Dufry and Autogrill join forces to redefine Travel Experience globally
Acer Therapeutics and Relief Therapeutics Announce That the China National Intellectual Property Administration (CNIPA) Issued Utility Model Patent 11,202,767 Covering ACER-001 Dosage Form
Acer Therapeutics and Relief Therapeutics Announce That the China National Intellectual Property Administration (CNIPA) Issued Utility Model Patent 11,202,767 Covering ACER-001 Dosage Form
DKSH Publishes Fifth Sustainability Report and Achieves 2025 Climate Target Ahead of Time
DKSH Publishes Fifth Sustainability Report and Achieves 2025 Climate Target Ahead of Time
Swiss Prime Site: largest certified property portfolio in Switzerland
Swiss Prime Site: largest certified property portfolio in Switzerland